Delivery Order SPE2D020D0009-SPE2D321F126S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $85,527.80, is for the delivery of Doxycycline Hydrochloride Injection (10) to support military medical facilities worldwide. The contract is structured as a delivery order with a firm fixed price and does not have a set-aside designation. Fresenius Kabi is a...
- This federal contract award, identified as SPE2D020D0009|SPE2D324F287B, was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection (10) and has a ceiling value of $53,143.79. The contract is structured as a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 27, 2024. Fresenius...
- This federal contract award is for the delivery of doxycycline hydrochloride injection to the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $19,442.85, was awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order under an indefinite delivery vehicle (IDV) and has a completion date of September 27, 2024. The contract is structured as a firm fixed-price arrangement...
- This federal contract award, SPE2D020D0009|SPE2D324F286Z, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $110,176.15 firm fixed-price delivery order is for the supply of Doxycycline Hydrochloride Injection (10), a critical care pharmaceutical, with a completion date of September 27, 2024. Fresenius Kabi, LLC is a major supplier of injectable...
- This federal contract award is for the delivery of Doxycycline Hydrochloride Injection (10) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order with a firm fixed price of $22,035.23 and a completion date of September 27, 2024. There is no set-aside designation associated with this contract. Fresenius Kabi, LLC...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned for-profit pharmaceutical company. The contract is for the delivery of 10 units of Doxycycline Hydrochloride Injection, a critical antibiotic medication, with a ceiling value of $83,365.00 and a period of performance ending on November 22, 2017. This award is not designated as a set-aside contract. Fresenius Kabi USA, LLC has been awarded numerous...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The $443,723.27 contract is for the delivery of injectable drugs, intravenous solutions, and other pharmaceutical products. This order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, a government-wide acquisition vehicle managed by the Department of Veterans Affairs. The contract does...
- This federal contract award, valued at $1,778.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of calcium gluconate injection, a critical care pharmaceutical product, with a completion date of November 22, 2024. Fresenius Kabi is a significant supplier of injectable medications and medical solutions to federal government...
- This federal contract award, identified as SPE2D020D0009|SPE2D325F0805, was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $14,074.76 Firm Fixed Price Delivery Order contract is for the supply of 4,566,185,308 units of Vancomycin 1 GM Vials, a critical care pharmaceutical product used by military and federal healthcare facilities. The contract has an ultimate completion date of October...
- SPE2D020D0009Indefinite Delivery Contract
- SPE2D020D0009-SPE2D321F126SDelivery Order
This federal contract award, SPE2D020D0009|SPE2D321F126S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of Doxycycline Hydrochloride Injection, a critical care pharmaceutical, with a total ceiling value of $87,387.10. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Fresenius Kabi, LLC has an established presence as a key supplier of injectable medications and infusion therapies to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the VA National Acquisition Center for the cancer treatment drug Bortezomib, valued at $2.24 million over five years, further demonstrating its capabilities in managing large-scale pharmaceutical supply contracts for critical medical treatments across various federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $87.4k | 6/15/21 |